Michel Dahan, SVP, Chief Operating Officer at Akebia Therapeutics, Inc. (AKBA), sold 190,956 shares at $1.22 ($233K) on 2023-05-25, disclosed to the SEC on 2023-05-25.
Open-market sale of $233k AKBA by SVP, Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 95,478 | $116K | 50.0% |
| 2 | $1.22 | 95,478 | $116K | 50.0% |
| Total | $1.22 avg | 190,956 | $233K | 100% |
| Filing → |
| AKBA | SELL | 2024-02-29 | $16K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $18K | — | Filing → |
| AKBA | SELL | 2023-03-01 | $8K | — | Filing → |